One-Year Work Retention After Prevention in 1,486 Patients
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Reader question: How many patients remained in high-risk work one year after a multi-component tertiary-prevention program?
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 1,486 patients from varied high-risk occupations who received a German tertiary individual prevention program for severe occupational skin disease between 1994 and 2003. |
| Design | Program cohort followed by a standardized questionnaire one year later. |
| Comparator | Work retention by reported motivation, employer provision of skin protection, age, ongoing dermatology care and occupation. |
| Timepoint | One year after the intensive inpatient, education and outpatient program. |
| Key result | 1,164/1,486 (78%) returned the questionnaire; 764/1,164 respondents (66%) remained in their risk profession. Retention was associated with self-protection motivation, employer-provided protection, older age and longer outpatient dermatology follow-up (all P<.001). |
| Funding/conflict context | The PubMed XML lists no grant or conflict statement. |
What was actually measured?
1,164/1,486 (78%) returned the questionnaire; 764/1,164 respondents (66%) remained in their risk profession. Retention was associated with self-protection motivation, employer-provided protection, older age and longer outpatient dermatology follow-up (all P<.001).
The outcome is work retention among respondents after a multi-component program, not a randomized estimate of program efficacy. Associations with motivation or employer support may reflect broader workplace conditions.
The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.
What the result does not prove
No untreated control, 22% nonresponse, self-reported exposures, multi-component care and historical German program conditions limit causal and international generalization.
Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.
A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.
Exposure detail matters more than the job label
Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.
A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.
Questions worth recording
- Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
- Where did the change begin, and did it improve on days away or after a process or PPE change?
- How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
- Were labels, ingredient information and safety-data sheets reviewed with occupational health?
- Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?
Prevention comes before cosmetic care
Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.
Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.
Primary research and guidance
- Primary research record: PubMed PMID 18239930
- NIOSH: occupational skin exposure
- NIAMS: atopic dermatitis
- American Academy of Dermatology: eczema skin care
Where Dr. Arsy #003 fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.
Continue the evidence series
- Work-Loss Surveillance Across 8,835 U.S. Occupational Dermatitis Cases
- Occupational Hand Dermatitis Among 94 Shrimp-Production Respondents
- One-Year Foot-Dermatosis Prevention Follow-Up in 231 Workers
- Hand-Eczema Frequency and Quality of Life in 46 Patients
Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.